CVS Caremark Boosts Dividend 22%, Sets $6 Billion Buyback

CVS Caremark Corp. (CVS), the largest provider of prescription drugs in the U.S., boosted its dividend by 22 percent and approved a share buyback for as much as $6 billion.

The quarterly dividend of 28 cents a share is payable Feb. 3 to holders of record on Jan. 23, the Woonsocket, Rhode Island-based said in a statement. The share repurchase is effective immediately and will be completed over a period of several years.

Adjusted profit will be $4.36 to $4.50 in 2014, the company said. Analysts had projected $4.47, on average.

CVS rose 4.3 percent to $69.69 at the close in New York. The shares have added 44 percent this year, compared with a 27 percent gain for the Standard & Poor’s 500 Index.

To contact the reporter on this story: Niamh Ring in New York at

To contact the editor responsible for this story: Cecile Daurat at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.